Providers’ compliance to malaria treatment using...

In the News

Muhas don is new IHI board member

Prof. Kaaya. Ifakara Health Institute (IHI) Board of Governors (BOG) has appointed Prof. Sylvia Kaaya member of the IHI Board of Trustees (BOT) effective Wednesday January 10, 2018. The appointment …

Marcel steps down from IHI boards

Prof. Marcel Tanner has stepped down as Ifakara Health Institute (IHI) member of the Board of Trustees (BOT) and Board of Governors (BOG) effective Wednesday January 10, 2018. The Former …

Recent Projects

Development of a new tool for malaria mosquito surveillance to improve vector control

Malaria transmission is influenced not only by vector abundance, but as well by demographic traits such as vector species and age structure, as these influence the intensity by which the …

Demonstrating complete disruption of residual malaria transmission by eliminating Anopheles funestus mosquitoes from rural Tanzanian villages

In rural south-eastern Tanzania, where malaria prevalence has reduced by >60% since 2000, low-to-moderate transmission still persists despite very high coverage with long-lasting insecticidal bednets. Like in most residual transmission …

Intervention on Providers' Compliance to Malaria Treatment (Arteseminin based Combination Therapy-ACTs) in Tanzania

This is a cluster randomized controlled trial at 52 health care facilities in Rufiji District, rural Tanzania. aimed at we developed to determine whether text message reminders delivered to health workers mobile phones can improve health workers’ poor compliance with the national malaria treatment guideline. Half of the health facilities are randomly allocated to an intervention group in which all health workers’ mobile phones receive text message reminders on malaria case management for 6 months. The other half serves as a control arm. Health workers re-training on case management was done before the intervention in both study arms by National Malaria Control Program. The primary outcome measure is correct management with artemether-lumefantrine (AL) defined as dichotomous composite indicator of correct testing and treatment tasks consistent with Tanzania treatment guideline.–

Lead Scientists:

Rashid A. Khatib


No items found


No items found

Projects Location

© Ifakara Health Institute (IHI), 2016